COVID-19 clinical trials: learning from exceptions in the research chaos

Saved in:

Bibliographic Details
Published in:	Nature medicine Vol. 26; no. 11; pp. 1671 - 1672
Main Authors:	Tikkinen, Kari A. O., Malekzadeh, Reza, Schlegel, Martin, Rutanen, Jarno, Glasziou, Paul
Format:	Journal Article
Language:	English
Published:	New York Nature Publishing Group US 01-11-2020 Nature Publishing Group
Subjects:	692/699/255/2514 706/648/1496 706/648/179 706/648/264 706/648/453 Biomedical and Life Sciences Biomedical Research - history Biomedical Research - organization & administration Biomedical Research - standards Biomedicine Canada - epidemiology Cancer Research Clinical trials Clinical Trials as Topic - methods Clinical Trials as Topic - organization & administration Clinical Trials as Topic - standards Community Networks - organization & administration Community Networks - standards Correspondence COVID-19 COVID-19 - diagnosis COVID-19 - epidemiology COVID-19 - therapy Drug Evaluation, Preclinical - methods Drug Evaluation, Preclinical - standards Europe - epidemiology History, 21st Century Humans Infectious Diseases International aspects International Cooperation Learning Metabolic Diseases Molecular Medicine Neural Networks, Computer Neurosciences Organizational Innovation Pandemics - history Patient Selection Pragmatic Clinical Trials as Topic - methods Pragmatic Clinical Trials as Topic - standards Research Design Scandinavian and Nordic Countries - epidemiology United Kingdom - epidemiology World Health Organization - organization & administration Canada United Kingdom Europe Scandinavian and Nordic Countries United States
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	SourceType-Books-1 ObjectType-Article-2 content type line 6 ObjectType-Correspondence-1 ObjectType-Feature-3
ISSN:	1078-8956 1546-170X
DOI:	10.1038/s41591-020-1077-z